This Program is dedicated to the training of cardiovascular scientists with MD and/or PhD degrees. Over the past 20 years, the program has focused on producing new leaders in fundamental cardiovascular science. Areas of investigation include developmental biology, signal transduction, vascular and myocardial biology, complex multigenic disorders, molecular imaging, cardiac stem cell biology, metabolomics, and high-throughput chemical genetic screening. Graduates of the Training Program have been highly successful in terms of publications in high-profile journals, obtaining extramural funding, and securing outstanding faculty positions. The program is based at the Cardiovascular Research Center at the Massachusetts General Hospital with additional training sites at Harvard Medical School and Harvard University, as well as the Massachusetts Institute of Technology and the Broad Institute. New faculty have been recruited to enable trainees to benefit from dramatic recent advances in cardiovascular science, including genome wide association studies and induced pluripotent stem cells. The new faculty members are recognized leaders in their evolving fields, as well as proven, outstanding mentors. Training is firmly centered on laboratory science under the supervision of skilled primary and secondary mentors, with unique opportunities for innovation at the interface between fields and supervised development of interdisciplinary collaborative skills. Didactic experiences are tailored to the needs of the trainee and are designed to broaden their exposure to the forefront of cardiovascular science and provide science """"""""survival skills"""""""". The faculty and trainees are closely linked by the tradition of collaboration and a shared training mission. Importantly, an enhanced CVRC seminar series, CVRC retreat, and Science Social/Hot Topics meetings serve to bring trainees together on a regular basis and provide a sense of community. Trainee progress is closely monitored by the mentors, the Program Director and co-Directors, and a Steering Committee, with additional advice provided by an External Advisory Committee. Outstanding mentorship is taught, evaluated, and celebrated. As demonstrated by the strong track record of this Training Program, graduates are rigorously and systematically prepared to lead independent research programs at the cutting edge of cardiovascular science for the coming decades.
This Program trains cardiovascular scientists with MD and/or PhD degrees to lead independent research programs at the cutting edge of fundamental cardiovascular science. Research career development centers on experiences in the laboratory supplemented by coursework and seminars tailored to the trainee's experience and needs. The faculty and trainees are closely linked by a tradition of outstanding mentorship which is taught, evaluated, and celebrated.
|Benson, Mark D; Yang, Qiong; Ngo, Debby et al. (2018) Genetic Architecture of the Cardiovascular Risk Proteome. Circulation 137:1158-1172|
|Hu, Ray; Morley, Michael P; Brandimarto, Jeffrey et al. (2018) Genetic Reduction in Left Ventricular Protein Kinase C-? and Adverse Ventricular Remodeling in Human Subjects. Circ Genom Precis Med 11:e001901|
|Jacob, Jaison; Ngo, Debby; Finkel, Nancy et al. (2018) Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions. Circulation 137:1270-1277|
|Khera, Amit V; Chaffin, Mark; Aragam, Krishna G et al. (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50:1219-1224|
|Jordi, Josua; Guggiana-Nilo, Drago; Bolton, Andrew D et al. (2018) High-throughput screening for selective appetite modulators: A multibehavioral and translational drug discovery strategy. Sci Adv 4:eaav1966|
|Tucker, Nathan R; McLellan, Micheal A; Hu, Dongjian et al. (2017) Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy. Circ Cardiovasc Genet 10:|
|Tucker, Nathan R; Dolmatova, Elena V; Lin, Honghuang et al. (2017) Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential. Circ Cardiovasc Genet 10:|
|Strauss, David G; Vicente, Jose; Johannesen, Lars et al. (2017) Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study. Circulation 135:1300-1310|
|Hucker, William J; Hanley, Alan; Ellinor, Patrick T (2017) Improving Atrial Fibrillation Therapy: Is There a Gene for That? J Am Coll Cardiol 69:2088-2095|
|Paffett-Lugassy, Noelle; Novikov, Natasha; Jeffrey, Spencer et al. (2017) Unique developmental trajectories and genetic regulation of ventricular and outflow tract progenitors in the zebrafish second heart field. Development 144:4616-4624|
Showing the most recent 10 out of 188 publications